ArticleJournal of neurology, neurosurgery, and psychiatry2014

Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?

Masahiro Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.